IV Therapy Consent Form Template for Med Spas & IV Bars

Not medical or legal advice. This guide explains how IV therapy consent documents are commonly structured and what they typically cover. It does not recommend any infusion, ingredient, amount, rate, volume or schedule, it does not set a clinical standard, and it does not describe the law of any particular state. Your medical director must approve every consent form before a patient signs it, and healthcare counsel familiar with your state should review it.

IV hydration and vitamin infusions have moved from hospital wards and infusion centres into med spas, stand-alone drip lounges and mobile services that visit homes, hotels and offices. The setting changed; the act did not. A vein is accessed, a sterile preparation is infused, and the patient sits with a line in their arm for a stretch of time while staff watch for problems. When something goes wrong, the consent form is one of the first documents a board investigator, insurer or plaintiff's lawyer asks to see, and in this service line it is frequently the weakest page in the chart.

The usual failures are easy to recognise. The form names a menu item rather than what was actually infused. It promises energy, immunity or recovery. It lists contraindications as if the patient were qualified to rule themselves out. It says nothing about the line slipping out of the vein, about stopping the drip, or about what happens if the patient feels unwell an hour after leaving. This guide works through each element in the order a patient experiences the visit, without a single amount, rate or schedule, because those are clinical decisions for the order and the protocol, not for a page the patient signs.

Is an IV Therapy Consent Form the Same as Informed Consent?

No. Informed consent is the discussion in which a qualified person explains the infusion, the alternatives and the risks, answers the patient's questions and confirms their decision; the signed form is evidence that the discussion happened. An IV chart needs both, and a form signed at a kiosk with nobody clinical in the room evidences very little.

IV services are especially exposed to that gap because the business model rewards speed. A patient books a named drip online, fills in a tablet at check-in, and is seated in a recliner within minutes. If that patient later develops a painful swollen arm or feels faint on the drive home, the questions asked of the practice will be precise. Who decided this infusion was appropriate for them? Was the order written for them, or was a menu item simply pulled from the fridge? Did anyone explain what infiltration is and ask them to speak up if the site hurt? Were they told they could stop at any time? A form designed around those questions helps answer them. A form copied from a competitor's website does not.

What the discussion adds to the signature

A printed page reads the same way to every patient. The conversation is where it becomes specific to the person in the chair. Someone with a history of fainting at blood draws, someone with a kidney condition they consider minor, someone who has just started a new prescription, and someone who had a rash after their last drip at another business all need something different said before the line goes in. Whoever leads the discussion ought to be able to recall what was raised for this particular patient and the outcome, and a sentence or two in the chart should capture it.

What a signed form can and cannot prove

The most a signed IV consent can establish is that a named patient agreed, on a stated date, to a described infusion after reading the text in front of them. It cannot show the patient was actually evaluated, that the infusion was ordered for them, or that the person who started the line was permitted to do so. Those facts live in other records. A form dated after the infusion began, or one naming a drip the patient never received, damages the chart rather than protecting it.

Who Evaluates, Orders and Starts the IV?

IV therapy requires an appropriate medical evaluation and an order for the patient before anything is infused, and the consent discussion follows from that evaluation rather than replacing it. Who may perform the evaluation, who may write the order and who may place and run the IV all vary by state, so confirm your state's rules before staffing the service.

Our IV therapy compliance guide covers scope, supervision, standing orders and the protocol set an IV program needs, and our good-faith exam guide by state covers the evaluation that has to come before treatment. This page deals only with the consent document that sits alongside them.

What Must an IV Therapy Consent Form Include?

An IV therapy consent form must name the infusion ordered and list its ingredients as the order lists them, state that it is not a substitute for medical care, and set out alternatives, common effects and each material risk. It adds screening questions for the evaluating practitioner, the patient's right to stop, post-infusion monitoring and warning signs, an emergency contact, and dated signatures.

Use the list below to audit the form you use today. Each item is explained in the sections that follow.

1. The infusion ordered — the infusion the patient is consenting to, identified by what it is rather than by a menu name alone, with each ingredient listed as the order lists it.
2. Not a substitute for medical care — a plain statement that the infusion does not diagnose or treat illness and does not replace care from the patient's own clinicians.
3. Alternatives — including oral fluids and diet, seeing their own clinician, and choosing no infusion.
4. Common effects — the expected, short-lived sensations of having a cannula placed and an infusion run, kept apart from the risks.
5. Risks to disclose — pain or bruising at the site, infiltration, phlebitis, infection, allergic reaction, fluid or electrolyte effects, and rare serious reactions.
6. Screening questions — heart, kidney or liver conditions, pregnancy or breastfeeding, current medicines and supplements, and prior reactions, answered by the patient and reviewed by the evaluating practitioner.
7. The right to stop — that the patient may ask for the infusion to be slowed or stopped at any time, and that staff may stop it too.
8. Post-infusion monitoring and warning signs — that the patient will be observed before leaving, and which symptoms afterwards mean they should get help.
9. Emergency contact — the practice's number, including out of hours, and an instruction to call emergency services for severe symptoms.
10. Signatures and date — the patient's attestation, signature and date, the name, credential and signature of the practitioner who held the discussion, and the form version.

The infusion ordered, identified properly

Start with what will actually go into the vein. A menu name is marketing, not a description. The form should identify the infusion the patient is agreeing to and list every ingredient as the order lists it, so that the document a patient signed can later be matched to the order and to the record of what was given. If your medical director wants the amounts that appear in the order reproduced on the form, they should be copied from the order for that patient, never from a menu, a supplier's brochure or a template.

Practices that offer a menu of preset infusions often choose a short form per infusion, with the ingredient list printed and checked against the order before use. Practices that build infusions to order usually use a single form with a field completed from the order before the patient signs. Either can work, provided no patient signs a form that names something different from what they receive. Add-ons matter too: a supplementary ingredient added at the chair is a change to the infusion, and the form and the order should both reflect it before it is given.

A clear statement that IV therapy is not a substitute for medical care

Patients often book an infusion because they feel unwell: exhausted, dehydrated after an illness, run down before a trip. The form should say plainly that the infusion is not a diagnosis, does not treat any disease, and is not a replacement for seeing their own physician or for emergency care. It should also say that if the evaluating practitioner thinks the patient's symptoms need medical assessment elsewhere, the practice will say so and may decline to proceed. That sentence protects the patient whose fatigue has a cause nobody has looked for, and it protects the practice from the suggestion that it treated an illness it never investigated.

Alternatives the patient could choose

A valid consent shows the patient knew there were other choices. For most wellness infusions those include drinking fluids, adjusting diet, taking oral supplements where their own clinician agrees, seeing their own clinician about the symptoms that prompted the visit, and deciding not to have an infusion at all. Nobody expects the page to rank those options or sell against them. What matters is a record that they were mentioned and the patient opted for the infusion anyway.

Common effects to expect

List the ordinary sensations separately from the risks, so that a patient is not alarmed by something expected and does not dismiss something that is not. Typical entries include a brief sting or pinch when the cannula is placed, a cool feeling in the arm as the fluid runs, a taste or smell some ingredients can produce, a need to pass urine during or after the infusion, and mild tenderness at the site afterwards. The form should say these usually settle quickly and that the patient should still tell staff about anything that feels different from what was described.

Risks the form must name

Each of the following belongs on its own line, in everyday language, with a short explanation of what it would mean for the patient. These are the entries a reviewer reads first after an IV complaint.

• Pain, bruising or bleeding at the site. Placing a cannula can hurt, may take more than one attempt, and can leave a bruise or a small bleed that takes time to clear.
• Infiltration. The cannula can move out of the vein so that fluid collects in the surrounding tissue, causing swelling, coolness, tightness or pain around the site. Ask the patient to report any of these straight away, because the infusion needs to stop.
• Phlebitis. The vein can become irritated or inflamed, causing redness, warmth, tenderness or a hard, cord-like feeling along it, sometimes appearing after the patient has gone home.
• Infection. Any break in the skin carries a risk of infection at the site and, rarely, more widely. Spreading redness, pus, increasing pain or fever need prompt assessment.
• Allergic reaction. A patient can react to an ingredient, a preservative, the skin preparation or the materials used. Reactions range from itching or a rash to a severe reaction needing emergency treatment, and the form should say the practice keeps emergency medicines and equipment and staff trained to use them.
• Fluid or electrolyte effects. Infusing fluid and minerals changes the balance in the body. Most people tolerate this well, but some medical conditions and medicines make it more significant, which is why the screening questions matter and why the patient should report breathlessness, swelling, palpitations or unusual weakness.
• Rare serious reactions. State plainly that serious complications are uncommon but possible, and that the practice has a plan for them, including calling emergency services.

Your medical director may add further entries depending on what you infuse and how, such as fainting during cannula placement, nerve irritation at the site, or risks specific to particular ingredients. Where testing is required before certain ingredients under your protocol, the form can say that such testing may be required without stating the clinical rule. Keep the explanation of how each complication is managed out of the consent; that belongs in the protocol.

Screening questions for the evaluating practitioner

Either on the form or in a linked intake document, ask the patient a short set of questions, with a place for the evaluating practitioner to record that they reviewed the answers before the infusion was ordered. Present these as questions that feed a clinical judgement, not as rules the patient applies to themselves. Whether any answer means proceeding, changing the order, postponing or declining is the evaluating practitioner's decision under the protocol your medical director has approved, and the form should say so. Typical questions include:

• Do you have, or have you ever been told you have, a heart condition, including heart failure, an irregular heartbeat or high blood pressure?
• Do you have, or have you ever been told you have, a kidney condition or reduced kidney function?
• Do you have, or have you ever been told you have, a liver condition?
• Is there any chance you are pregnant, are you trying to become pregnant, or are you breastfeeding?
• What prescription medicines, over-the-counter medicines, vitamins and supplements are you taking, and has anything changed recently?
• Have you ever had a reaction to an infusion, an injection, a vitamin, a medicine, latex, adhesive tape or a skin cleanser?
• Have you ever fainted or felt faint having blood taken or a cannula placed?
• Are you unwell today, and what made you decide to book this infusion?

Your medical director may add questions specific to particular ingredients or to your patient population. The patient signs and dates the completed answers; the evaluating practitioner initials them as reviewed before the order is written. If an answer changed the plan, record the change in the evaluation note rather than on the consent.

Resist the temptation to print rules next to the questions, such as which conditions rule out an infusion or which medicines must be paused. Those are protocol decisions that differ by ingredient and patient. A rule printed for the patient to apply invites them to answer the question in a way that gets them their drip, and it risks contradicting the protocol your medical director actually signed. Keep the question on the form and the rule in the protocol. For the wider health history behind these questions, see our intake form template guide.

The patient's right to stop the infusion

The form should state that the patient may ask for the infusion to be slowed or stopped at any point, for any reason, and that doing so will not affect their future care. It should also say that staff will stop the infusion if they have a safety concern, and that a stopped infusion may not be restarted that day. Patients who are paying for a package sometimes feel they must finish what they bought; saying in writing that stopping is always acceptable makes it more likely they will mention the swelling or the strange taste early. Your refund or credit policy for a stopped infusion belongs on the financial policy, not here.

Post-infusion monitoring and warning signs

Tell the patient that staff will watch them during the infusion and observe them for a period afterwards before they leave, as your protocol sets out, and that they should not leave early without telling a staff member. If the patient chooses to leave against advice, the chart should say so. Mobile services need particular care here: the form should explain how monitoring works in a home or hotel room and what the clinician will do if the patient becomes unwell there.

Then list the warning signs that mean the patient should get help after leaving: swelling, hardness, redness, warmth or increasing pain in the arm; a red line spreading along the vein; fever or chills; a rash, itching or swelling of the face, lips or tongue; breathlessness, chest tightness or wheezing; a racing or irregular heartbeat; dizziness, fainting or confusion; and swelling of the ankles or unusual weakness. Make the distinction between "call the practice" and "call emergency services" clear, and say that breathing difficulty, throat tightness or collapse always mean emergency services first.

Emergency contact

Print the practice's number and say who answers it outside opening hours. If nobody does, say where the patient should go instead. For mobile services, give the number of the business, not the personal mobile of a clinician who may be on another visit. The number on the consent should be the same one on the aftercare sheet, and someone should check periodically that it still works.

Signatures, date and the practitioner's identity

End with a short attestation in the patient's own voice: they read the form, were invited to ask questions and had them answered, gave truthful answers to the screening questions, and agree to the named infusion. The patient signs and dates it before the cannula is placed. Under that, the practitioner who held the discussion prints their name and credential and signs. If a different person places the IV, record their name in the treatment note. Print the form version in the footer. Ask counsel whether your state or your insurer expects a witness, and if one signs, make sure they actually watched the patient sign.

Can an IV Consent Form Make Health Claims?

No. A consent form is a risk disclosure, not a sales page, and neither the form nor the menu should claim that an infusion boosts immunity, cures a hangover, improves energy or treats any condition unless the practice holds evidence that genuinely supports that claim. Unsupported efficacy claims on a signed document can be read as a promise the practice did not keep.

The temptation comes from the menu. Infusions are often sold under names that describe a hoped-for outcome, and the consent form inherits the name and the description beside it. Strip both out. Describe the infusion by its ingredients and the order, and describe expected results honestly: effects vary between people, some people notice nothing, and the practice does not promise any particular benefit. The Federal Trade Commission expects health claims in advertising to be supported by competent and reliable scientific evidence, and state boards look unfavourably on clinical services marketed with promises the evidence does not support. A consent form that repeats the marketing hands a complainant the evidence they need.

The same discipline applies to everything around the form: the booking page, the treatment room signage, the social posts and what staff say at the chair. If the menu says one thing and the consent says another, the patient will remember the menu.

Is There a Free IV Therapy Consent Form PDF?

Yes, plenty of IV consent PDFs circulate online, and none should be used as downloaded: treat any of them as a starting point only. Before a patient signs it, the form must match the infusions on your actual formulary, the way your practice evaluates patients and writes orders, and your state's law, and your medical director must approve the final wording.

Downloaded IV forms go wrong in recognisable ways. Many were written for one company's menu and name drips you do not offer. Many print amounts, rates or session frequencies that nobody in your practice approved. Some describe a nurse deciding who is suitable, which may not reflect who is permitted to evaluate and order in your state. Some list contraindications as rules for the patient to apply. Many repeat wellness claims from the original business's marketing. And a surprising number say nothing about infiltration, the right to stop or what to do after leaving.

Used carefully, a free template can help you spot gaps by comparing it with the elements listed earlier. Then draft your practice's version around your own formulary and process, note who approved it and the date it took effect, and have healthcare counsel look at it before the first patient signs.

How Should You Document an IV Infusion Alongside the Consent?

A signed IV consent is thin evidence by itself. Filed with the evaluation note, the order, the reviewed screening answers and a complete infusion record, it becomes part of a coherent account of the visit. On its own, it shows only that a patient signed something.

What the infusion record should capture

Every infusion should leave a record that includes the order the infusion was given under, including who wrote it and when; the preparation infused, with the lot numbers of the products used; the site of the IV and the cannula used; the start and stop times; the observations made during the infusion and the monitoring after it, as your protocol requires; any problem, interruption or reaction and what was done; the condition of the site when the cannula was removed; the time of discharge; and the name and credential of each person involved. Which values are recorded, and how often, is for your protocol to specify. The point is that the entry is completed for each infusion, not copied forward from the last visit.

Lot numbers deserve particular emphasis. If a supplier later recalls a product, the practice needs to know which patients received it, and that is impossible without lot-level records. The same applies to documenting where products were sourced, which our IV compliance guide covers as part of the storage and handling protocol.

How long to keep signed IV consent forms

Signed consent forms are part of the medical record and share its retention period, which is set by state law and related obligations rather than by the type of treatment. Keep every superseded version of the template as well, so you can show what a particular patient actually read and signed. To identify which period governs your IV charts, start with our medical records retention guide.

When Does an IV Patient Need to Re-Consent?

IV patients often return regularly, and every practice needs a written rule on when a fresh consent is signed. The simplest rule is a new consent for each infusion visit, which also keeps screening current. Practices that use a longer-lasting consent should, at minimum, take a fresh signature whenever:

• The formulary changes, including a new infusion, a changed ingredient list for an existing one, or a new add-on, because the form the patient signed no longer describes what they would receive.
• The patient receives a different infusion from the one their consent named.
• The patient's health, medicines or pregnancy status changes, as picked up when the screening questions are asked again.
• The patient had a reaction or problem at a previous infusion, which needs discussing before the next.
• The template is revised, so returning patients are on current wording.
• The setting changes, for example from the clinic to a mobile visit, where monitoring and emergency arrangements differ.

Whichever approach you take, the evaluation behind each infusion must still be current under your protocol; a consent signed months ago does not stand in for that. What is hard to defend is having no written rule, or one applied differently by each staff member.

What Should the Form Say About Reactions and Emergencies?

Enough for the patient to understand that reactions can happen, that the practice is prepared for them, and what they will be asked to do. The consent is not the place to describe emergency treatment. That belongs in the written protocols your staff train on.

On the form, a short paragraph is usually enough: the practice keeps emergency medicines and equipment on site or with the mobile clinician; staff are trained to recognise and respond to reactions; if a serious reaction occurs, staff will stop the infusion, give emergency treatment as their protocol directs and call emergency services; and the patient agrees to that emergency care. Some practices add a line asking who the practice may contact on the patient's behalf in an emergency, with the name and number recorded at check-in.

Behind that paragraph sits the real preparation. Our anaphylaxis protocol guide explains recognition, response and documentation for severe allergic reactions, and our emergency protocol checklist covers the supplies, roles and drills every clinical setting needs. Check that the emergency arrangements described on your consent form match what those protocols say and what is actually in the room or the mobile kit. Our Emergency Protocol Kit includes anaphylaxis, adverse medication reaction and when-to-call-911 SOPs for your medical director to adapt.

What Should an IV Therapy Consent Form Template Look Like?

A usable template follows the order of the visit and lets an auditor find each element quickly. The table gives section headings only. Your medical director writes the wording under each, and counsel reviews it.

A supplier's product sheet is not a consent form. Use labeling and supplier information as a source for what may need disclosing, then write the form in plain words your patients can follow.

Which IV Consent Mistakes Cause the Most Trouble?

IV complaints tend to expose the same few weaknesses. Most are not about a missing form but about a form that does not match what happened.

A menu name instead of an ingredient list

A form that says the patient consented to "the Recovery drip" proves nothing about what was in the bag, especially once the recipe has changed twice since the form was written. List the ingredients from the order and keep the menu name, if at all, as a label beside them.

Screening that reads like a self-assessment

Forms that tell patients "do not have this infusion if you have heart or kidney disease" invite them to decide their own eligibility. Many people do not know, or do not mention, a condition they think is minor. Ask the question, have the evaluating practitioner review the answer, and record the decision in the evaluation note.

Nothing about leaving

A surprising number of IV forms end when the infusion ends. Phlebitis and some reactions can appear after the patient has gone, and a patient who was never told what to look for, or whom to call, is badly placed to get help early. Warning signs and the emergency contact belong on the consent as well as on the aftercare sheet.

Mobile services using the clinic form unchanged

An infusion in someone's living room is not the same as one in a treatment room with emergency equipment down the corridor. If you offer mobile IV, the consent should describe how monitoring and emergencies work in that setting, and the mobile kit should match what the form says.

How Does the Consent Form Fit With Your IV Protocols?

The consent form, the evaluation template, the order, the infusion protocols, the aftercare sheet and the emergency protocols are different views of one service and have to agree. If the protocol screens for a condition, the form asks about it. If the protocol requires observation before discharge, the form tells the patient to expect it. The warning signs on the form and the aftercare sheet should be word-for-word the same. When the formulary changes, every one of these documents is reviewed together, and the consent is re-approved before the new infusion is offered.

Keeping a consistent structure across your procedure forms helps. Shared blocks for attestation, signatures and versioning make training and audits easier, while the infusion, risk and screening content stays specific to IV therapy. Our med spa consent forms guide maps where the IV form sits among the other documents a practice needs, and our neurotoxin consent guide and dermal filler consent form guide apply the same frame to injectables.

Key Takeaways

• The signed form records a discussion that follows an evaluation and an order for the patient; it replaces neither.
• Who may evaluate, order and start an IV depends on your state; confirm it before staffing the service.
• Name the infusion and list its ingredients as the order lists them; never rely on a menu name.
• Disclose each risk, put screening as questions for the evaluating practitioner, state the right to stop, and cover monitoring, warning signs and emergency contact.
• Make no health claims, re-consent when the formulary changes, and have every version approved by your medical director and reviewed by counsel.

This page offers general information about preparing and keeping IV therapy consent documents. It is not medical or legal advice, does not establish a standard of care and does not summarise the law of any state. Do not give the form to patients until your medical director has approved its wording and a healthcare lawyer has reviewed it.